Parkinson's Disease Treatment Market Report by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO Inhibitors, COMT Inhibitors, Anticholinergics, and Others), Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032

Parkinson's Disease Treatment Market Report by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO Inhibitors, COMT Inhibitors, Anticholinergics, and Others), Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A2792
Buy Now

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Parkinson’s Disease Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Carbidopa/Levodopa
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Dopamine Receptor Agonists
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    MAO Inhibitors
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    COMT Inhibitors
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Anticholinergics
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7   Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Transdermal
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Subcutaneous
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Intestinal Infusion
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacies
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AbbVie Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Acadia Pharmaceuticals Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio 
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
        14.3.4    F. Hoffmann-La Roche AG
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 SWOT Analysis
        14.3.5    GlaxoSmithKline Plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    H. Lundbeck A/S 
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Merck & Co. Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Mylan N.V.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Novartis AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Orion Corporation
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Sun Pharmaceutical Industries Ltd.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio 
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Teva Pharmaceutical Industries
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio 
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis
        14.3.13    Wockhardt Ltd. 
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio 
           14.3.13.3 Financial

List of Figures

Figure 1: Global: Parkinson’s Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Parkinson’s Disease Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Parkinson’s Disease Treatment Market: Breakup by Drug Class (in %), 2023
Figure 4: Global: Parkinson’s Disease Treatment Market: Breakup by Route of Administration (in %), 2023
Figure 5: Global: Parkinson’s Disease Treatment Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Parkinson’s Disease Treatment Market: Breakup by Region (in %), 2023
Figure 7: Global: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Parkinson’s Disease Treatment (Carbidopa/Levodopa) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Parkinson’s Disease Treatment (Carbidopa/Levodopa) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Parkinson’s Disease Treatment (Dopamine Receptor Agonists) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Parkinson’s Disease Treatment (Dopamine Receptor Agonists) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Parkinson’s Disease Treatment (MAO Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Parkinson’s Disease Treatment (MAO Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Parkinson’s Disease Treatment (COMT Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Parkinson’s Disease Treatment (COMT Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Parkinson’s Disease Treatment (Anticholinergics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Parkinson’s Disease Treatment (Anticholinergics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Parkinson’s Disease Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Parkinson’s Disease Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Parkinson’s Disease Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Parkinson’s Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Parkinson’s Disease Treatment (Transdermal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Parkinson’s Disease Treatment (Transdermal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Parkinson’s Disease Treatment (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Parkinson’s Disease Treatment (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Parkinson’s Disease Treatment (Intestinal Infusion) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Parkinson’s Disease Treatment (Intestinal Infusion) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Parkinson’s Disease Treatment (Other Routes of Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Parkinson’s Disease Treatment (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Parkinson’s Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Parkinson’s Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Parkinson’s Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Parkinson’s Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Parkinson’s Disease Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Parkinson’s Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: North America: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: North America: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: United States: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: United States: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Canada: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Canada: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Asia Pacific: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Asia Pacific: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: China: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: China: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Japan: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Japan: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: India: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: India: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: South Korea: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: South Korea: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Australia: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Australia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Indonesia: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Indonesia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Europe: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Europe: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Germany: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Germany: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: France: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: France: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: United Kingdom: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: United Kingdom: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Italy: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Italy: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Spain: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Spain: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Russia: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Russia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Latin America: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Latin America: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Brazil: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Brazil: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Mexico: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Mexico: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Middle East and Africa: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Middle East and Africa: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Global: Parkinson’s Disease Treatment Industry: SWOT Analysis
Figure 85: Global: Parkinson’s Disease Treatment Industry: Value Chain Analysis
Figure 86: Global: Parkinson’s Disease Treatment Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Parkinson’s Disease Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Parkinson’s Disease Treatment Market Structure
Table 7: Global: Parkinson’s Disease Treatment Market: Key Players

Parkinson's Disease Treatment Market Report by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO Inhibitors, COMT Inhibitors, Anticholinergics, and Others), Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More